Beta-blockers, depression, and anxiety after myocardial infarction: the BETAMI-DANBLOCK trial - PubMed
6 hours ago
- #Beta-blockers
- #Mental Health
- #Cardiology
- Beta-blockers are used after myocardial infarction (MI) for secondary prevention, but their effects on depression and anxiety are debated.
- The BETAMI-DANBLOCK trial investigated the impact of beta-blockers on depression and anxiety in patients with recent MI without heart failure.
- Results suggest that beta-blockers may have minimal adverse effects on mental health, potentially alleviating concerns about such side effects.